 |
BioWorld-Insight-2010-05-24
Answer to Melanoma Riddle: Not One, but Many Diseases
Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: April 1 - May 20, 2010
No Abstract
Answer to Melanoma Riddle: Not One, but Many Diseases
As the industry braces for an onslaught of data from the American Society of Clinical Oncology meeting next week in Chicago, debate continues about the chances that an approvable therapy will emerge for one of the deadlier, more challenging cancers - melanoma.